The treatment of medical cannabis through smoking does not allow patients who spend a significant part of their time in clinics, repeated hospitalizations, and rehabilitation to maintain continuity of pain reduction treatment. Research Podcast #2 describes a questionnaire study conducted at Rambam Health Care Campus in Haifa, Israel, among hospitalized patients with a cannabis license who could not consume their regular treatment during their hospitalization and, therefore, were prescribed the SyqeAir Inhaler, which can be used in hospitals (Syqe®’s second study, 2019)
Read the full article here and listen to this short podcast on the study (16 minutes):
